CCL18 and ovarian carcinoma: The panel of serum C-C motif chemokine ligand 18 (CCL18) and C-X-C motif chemokine ligand 1 (CXCL1) antigens combined with nucleic acid-binding protein (C1D), fragile X mental retardation syndrome-related protein 1 (FXR1), zinc finger protein 573 (ZNF573) and transmembrane 4 L six family member 1 (TM4SF1) AAbs showed an AUC of 0.99 for ovarian cancer diagnosis, an AUC of 0.95 for early-stage ovarian cancer, and an AUC of 0.75–0.96 for discriminating patients with ovarian cancer from patients with other malignancies [164].